X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ABBOTT INDIA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD ABBOTT INDIA ALEMBIC LTD/
ABBOTT INDIA
 
P/E (TTM) x 49.9 36.3 137.6% View Chart
P/BV x 2.0 9.4 21.7% View Chart
Dividend Yield % 0.5 0.7 68.2%  

Financials

 ALEMBIC LTD   ABBOTT INDIA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
ABBOTT INDIA
Mar-18
ALEMBIC LTD/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs726,110 1.2%   
Low Rs343,996 0.8%   
Sales per share (Unadj.) Rs4.71,552.2 0.3%  
Earnings per share (Unadj.) Rs6.1188.8 3.2%  
Cash flow per share (Unadj.) Rs6.2196.4 3.2%  
Dividends per share (Unadj.) Rs0.2055.00 0.4%  
Dividend yield (eoy) %0.41.1 34.7%  
Book value per share (Unadj.) Rs40.7796.6 5.1%  
Shares outstanding (eoy) m267.0321.25 1,256.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.33.3 346.0%   
Avg P/E ratio x8.726.8 32.4%  
P/CF ratio (eoy) x8.525.7 33.0%  
Price / Book Value ratio x1.36.3 20.5%  
Dividend payout %3.329.1 11.2%   
Avg Mkt Cap Rs m14,139107,376 13.2%   
No. of employees `000NA3.3 0.0%   
Total wages/salary Rs m2073,937 5.3%   
Avg. sales/employee Rs ThNM9,929.3-  
Avg. wages/employee Rs ThNM1,185.1-  
Avg. net profit/employee Rs ThNM1,207.7-  
INCOME DATA
Net Sales Rs m1,25532,985 3.8%  
Other income Rs m3701,170 31.6%   
Total revenues Rs m1,62534,155 4.8%   
Gross profit Rs m1115,245 2.1%  
Depreciation Rs m38162 23.3%   
Interest Rs m238 4.5%   
Profit before tax Rs m4426,215 7.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m242,203 1.1%   
Profit after tax Rs m1,6304,012 40.6%  
Gross profit margin %8.915.9 55.7%  
Effective tax rate %5.435.4 15.3%   
Net profit margin %129.812.2 1,067.5%  
BALANCE SHEET DATA
Current assets Rs m1,86722,655 8.2%   
Current liabilities Rs m5916,681 8.8%   
Net working cap to sales %101.648.4 209.9%  
Current ratio x3.23.4 93.1%  
Inventory Days Days9465 145.5%  
Debtors Days Days7429 252.3%  
Net fixed assets Rs m1,791835 214.4%   
Share capital Rs m534213 251.3%   
"Free" reserves Rs m10,32416,715 61.8%   
Net worth Rs m10,85816,928 64.1%   
Long term debt Rs m410-   
Total assets Rs m11,59124,162 48.0%  
Interest coverage x260.9163.7 159.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.11.4 7.9%   
Return on assets %14.116.8 84.0%  
Return on equity %15.023.7 63.3%  
Return on capital %15.236.9 41.1%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m19369 5.3%   
Fx outflow Rs m2643,807 6.9%   
Net fx Rs m-244-3,438 7.1%   
CASH FLOW
From Operations Rs m2361,527 15.4%  
From Investments Rs m-224-2,148 10.4%  
From Financial Activity Rs m-27-1,024 2.6%  
Net Cashflow Rs m-15-1,646 0.9%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.2 7.9 2.5%  
FIIs % 9.7 0.1 9,700.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 17.1 152.6%  
Shareholders   54,701 18,270 299.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   CIPLA  PFIZER  ALEMBIC PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  

Compare ALEMBIC LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Where Will the Two-Faced Market Go from Here?(Podcast)

The stock markets are very volatile these days. As the Tanushree Bannerjee, the co-head of research here at Equitymaster puts it, stock markets are two-faced.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

Feb 4, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Do You Have the Stomach to Survive a Small Cap Crash?(Profit Hunter)

Feb 5, 2019

While selecting good businesses is relatively easy task in a bearish phase, where most people fail is in having enough patience to hold the quality stocks until recovery.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 15, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS